ID   454A12
AC   CVCL_B0DN
DR   Wikidata; Q108819628
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   PubMed=1715033;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10804.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10075.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=US4938948;
RA   Ring D.B., Frankel A.E.;
RT   "Method for imaging breast tumors using labeled monoclonal anti-human
RT   breast cancer antibodies.";
RL   Patent number US4938948, 03-Jul-1990.
//
RX   Patent=US4956453;
RA   Bjorn M.J., Frankel A.E., Laird W.J., Ring D.B., Winkelhake J.L.;
RT   "Anti-human ovarian cancer immunotoxins and methods of use thereof.";
RL   Patent number US4956453, 11-Sep-1990.
//
RX   PubMed=1715033; DOI=10.1016/0161-5890(91)90056-p;
RA   Ring D.B., Clark R., Saxena A.;
RT   "Identity of BCA200 and c-erbB-2 indicated by reactivity of monoclonal
RT   antibodies with recombinant c-erbB-2.";
RL   Mol. Immunol. 28:915-917(1991).
//